Holm V A, Knox W E
Pediatrics. 1979 May;63(5):694-9.
A retrospective cross-sectional survey of phenylketonuria (PKU) was conducted in 1967. Questionnaires on 693 patients, clinically thought to have PKU, were reanalyzed to obtain information on growth in height and head circumference in patients with untreated and previously treated PKU. To provide a comparison to the growth findings of the Collaborative PKU Study, a definition of PKU was adopted to correspond to the one used in that study. Stature in 232 outpatients with untreated PKU was normal but, in 31 institutionalized individuals, the mean height was -1.4 standard deviations below the mean of a normal population. Head circumference in patients with untreated PKU was normal at birth, but showed an increasingly negative deviance with age and was -1.4 SD in untreated adults. Height measurements of 135 children with PKU in whom treatment was started before 121 days of age (age chosen to coincide with criteria for the Collaborative Study) had a significant reduction in height growth, -.8 SD. Head circumference measurements of 115 children treated for PKU were -.7 SD of normal. The depression in head circumference was less in treated subjects with PKU than in untreated ones of the same age. These findings are corroborated by a review of the literature, which contains no convincing report of normal growth during treatment of PKU.
1967年对苯丙酮尿症(PKU)进行了一项回顾性横断面调查。对临床诊断为PKU的693例患者的问卷进行重新分析,以获取未经治疗和先前接受过治疗的PKU患者身高和头围增长的信息。为了与PKU协作研究的生长结果进行比较,采用了与该研究中使用的PKU定义相对应的定义。232例未经治疗的PKU门诊患者的身高正常,但在31例住院患者中,平均身高比正常人群平均身高低1.4个标准差。未经治疗的PKU患者出生时头围正常,但随着年龄增长呈越来越大的负偏差,未经治疗的成年人头围为-1.4标准差。135例在121日龄之前开始治疗(选择该年龄以符合协作研究标准)的PKU儿童的身高测量显示身高增长显著降低,为-0.8标准差。115例接受PKU治疗儿童的头围测量值为正常的-0.7标准差。接受治疗的PKU患者的头围降低程度低于同年龄未接受治疗的患者。这些发现得到了文献综述的证实,该综述未包含PKU治疗期间正常生长的令人信服的报告。